Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Media

Press Releases - 2002

Newron Pharmaceuticals Expands Second Round Financing To € 25 Million -- Apax Partners Invests € 6.5 Million in Second Closing and Joins Board of Directors

23/07/2002
English ENG